Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | RXFP1 | Q9HBX9 | 1/20 | 0.43 |
| ▸ | MEN1 | O00255 | 2/20 | 0.42 |
| ▸ | KMT2A | Q03164 | 2/20 | 0.42 |
| ▸ | L3MBTL1 | Q9Y468 | 4/20 | 0.41 |
| ▸ | RAB9A | P51151 | 3/20 | 0.41 |
| ▸ | NPC1 | O15118 | 2/20 | 0.41 |
| ▸ | USP2 | O75604 | 1/20 | 0.41 |
| ▸ | CASP3 | P42574 | 1/20 | 0.41 |
| ▸ | SENP8 | Q96LD8 | 1/20 | 0.41 |
| ▸ | SENP7 | Q9BQF6 | 1/20 | 0.41 |
| ▸ | SENP6 | Q9GZR1 | 1/20 | 0.41 |
| ▸ | MAPT | P10636 | 2/20 | 0.41 |
| ▸ | CAPN1 | P07384 | 2/20 | 0.41 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.41 |
| ▸ | POLB | P06746 | 2/20 | 0.40 |
| ▸ | TDP1 | Q9NUW8 | 2/20 | 0.40 |
| ▸ | RECQL | P46063 | 1/20 | 0.40 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.40 |
| ▸ | CYP2D6 | P10635 | 1/20 | 0.40 |
| ▸ | CYP2C9 | P11712 | 1/20 | 0.40 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL29056506 | 0.91 | RXFP1 (0.45) | RXFP1MEN1KMT2AL3MBTL1RAB9A | |
| SCHEMBL29183304 | 0.87 | NPC1 (0.53) | MEN1KMT2ARAB9ANPC1MAPT | |
| SCHEMBL7770564 | 0.84 | KDM4E (0.43) | RXFP1RAB9ANPC1MAPTCAPN1 | |
| SCHEMBL10612639 | 0.82 | MAOB (0.55) | L3MBTL1RAB9ANPC1CAPN1ALDH1A1 | |
| SCHEMBL31088170 | 0.81 | KDM4E (0.49) | MEN1KMT2AL3MBTL1RAB9AMAPT | |
| SCHEMBL5445458 | 0.81 | KDM4E (0.49) | MEN1KMT2AL3MBTL1RAB9AMAPT | |
| SCHEMBL4145981 | 0.80 | TDP1 (0.49) | MEN1KMT2AMAPTCAPN1KDM4E | |
| SCHEMBL9578051 | 0.78 | MEN1 (0.53) | MEN1KMT2AL3MBTL1RAB9ANPC1 | |
| SCHEMBL10432798 | 0.78 | MAPT (0.50) | RAB9ANPC1MAPTALDH1A1SMN1; SMN2 | |
| SCHEMBL30384131 | 0.77 | MAPT (0.50) | MEN1KMT2ARAB9ANPC1MAPT |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-11643405-B2 | Compound for treatment or prevention of liver diseases | JIANGSU ATOM BIOSCIENCE AND PHARMACEUTICAL CO., LTD. (CN) | 2023-05-09 | — | — | US | disclosed |
| US-20210246126-A1 | COMPOUND FOR TREATMENT OR PREVENTION OF LIVER DISEASES | JIANGSU ATOM BIOSCIENCE AND PHARMACEUTICAL CO., LTD. (CN) | 2021-08-12 | — | — | US | disclosed |
| EP-3805216-A1 | COMPOUNDS FOR TREATMENT OR PREVENTION OF LIVER DISEASES | Jiangsu Atom Bioscience and Pharmaceutical Co., Ltd. (CN) | 2021-04-14 | — | — | EP | disclosed |
| US-20090092624-A1 | Antiinfective Flavononol Compounds and Methods of Use Thereof | HERBALSCIENCE GROUP, LLC | 2009-04-09 | — | — | US | disclosed |
| WO-2001007034-A1 | MULTIDRUG RESISTANCE PUMP INHIBITORS AND USES THEREOF | COLORADO STATE UNIVERSITY RESEARCH FOUNDATION (US) | 2001-02-01 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20210246126-A1 | COMPOUND FOR TREATMENT OR PREVENTION OF LIVER DISEASES | SLC10A1, GYS2, CPT1A | RXFP1 2374/4885MEN1 918/4885KMT2A 4405/4885 |
| US-20090092624-A1 | Antiinfective Flavononol Compounds and Methods of Use Thereof | MPO, VIP, FABP2 | RXFP1 3741/4885MEN1 2440/4885KMT2A 3717/4885 |
| US-11643405-B2 | Compound for treatment or prevention of liver diseases | SLC10A1, GYS2, CPT1A | RXFP1 2374/4885MEN1 918/4885KMT2A 4405/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.